Today: 31 January 2026
Subscribe
Browse Category

Market Analysis News 8 October 2025 - 9 October 2025

MEDIROM (NASDAQ: MRM) Set for Takeoff: Series A Boost & Altman-Backed ‘Orb’ Deal Fuels 150% Upside

MEDIROM (NASDAQ: MRM) Set for Takeoff: Series A Boost & Altman-Backed ‘Orb’ Deal Fuels 150% Upside

Company Background & Business Model MEDIROM Healthcare Technologies (NASDAQ: MRM) is a Tokyo‑based provider of holistic health and wellness services. Founded in 2000, it operates 300+ Re.Ra.Ku branded relaxation salons across Japan Medirom, offering massage, aromatherapy and lifestyle therapy. These salons generate the bulk of revenues (47.3M of $52.7M in 2024) Medirom. In parallel, since 2015 MEDIROM has built a…
9 October 2025
····
American Airlines (AAL) Stock Takes Off on Travel Demand – Will It Keep Climbing or Hit Turbulence?

American Airlines (AAL) Stock Takes Off on Travel Demand – Will It Keep Climbing or Hit Turbulence?

Stock Price and Recent Performance American Airlines’ stock has been on a turbulent ride in 2025. After starting the year in the high teens, AAL has sunk into the low double-digits – recently closing around $11.81 Marketbeat. The slide accelerated in September amid soft travel demand and pessimistic guidance. As of early October, shares were down over 34% year-to-date (vastly…
9 October 2025
····
Gold Hits $4,000 Record, Silver Soars to $50 – Rally to Continue or Crash Ahead?

Gold Hits $4,000 Record, Silver Soars to $50 – Rally to Continue or Crash Ahead?

Precious Metals Skyrocket to Historic Highs Gold and silver have been on a record-breaking tear in 2025. Gold entered the year around $2,800 and by October blasted past the $4,000/oz milestone – an unprecedented level ts2.tech ts2.tech. On October 7–8, spot gold surged to an all-time high near $4,078 before settling around $4,038 by Oct. 9 ts2.tech Reuters. This ~53%…
9 October 2025
····
Adaptimmune Stock’s Wild 2025 Ride: Speculative Surge or True Biotech Comeback?

Adaptimmune Stock’s Wild 2025 Ride: Speculative Surge or True Biotech Comeback?

Company Overview: Pioneering T-Cell Therapies for Cancer Adaptimmune Therapeutics plc is a UK-based biotech founded in 2008, specializing in T-cell receptor (TCR) engineered cell therapies to fight cancer ts2.tech. The company’s mission has been to “redefine how some of the most challenging-to-treat solid tumors are treated” by harnessing patients’ own T-cells and genetically equipping them to target cancer cells Adaptimmune.…
9 October 2025
···
Ethereum $5,000 Soon? Fed Cuts, Small-Cap Rally & Whale Moves Fuel Bold Forecasts

Ethereum $5,000 Soon? Fed Cuts, Small-Cap Rally & Whale Moves Fuel Bold Forecasts

Ethereum Rebounds Toward All-Time Highs Ethereum’s price is once again flirting with record territory after a volatile few weeks. The world’s second-largest crypto came within ~$200 of its all-time high in early October Decrypt. In late August, ETH actually set a new peak around $4,946 – finally eclipsing its 2021 high – before a sharp September correction Decrypt. By September…
9 October 2025
··
Jamie Dimon’s Dire Warning: “Serious” Stock Market Correction Could Hit Soon

Jamie Dimon’s Dire Warning: “Serious” Stock Market Correction Could Hit Soon

Dimon Sounds the Alarm on a “Serious” Market Correction Jamie Dimon – one of Wall Street’s most influential bankers – is ringing alarm bells about the soaring U.S. stock market. In an interview with the BBC, the JPMorgan CEO warned that U.S. equities could suffer a major correction within 6 months to 2 years Reuters. “I am far more worried…
9 October 2025
····
PepsiCo’s Sneaky Q3 Beat: Earnings Up, New CFO In, But U.S. Snack Sales Slump – What It Means

PepsiCo’s Sneaky Q3 Beat: Earnings Up, New CFO In, But U.S. Snack Sales Slump – What It Means

Q3 Earnings: Small Beat Hides Big Shifts PepsiCo’s third-quarter results delivered a mixed bag. On the headline numbers, the snack and beverage giant slightly beat Wall Street expectations – a welcome surprise given tempered forecasts. Core earnings per share of $2.29 edged past consensus, and net revenue of $23.9 billion marked modest growth Seekingalpha. The company managed this top-line increase…
9 October 2025
··
Silver Soars to Record Highs as Gold Hits $4,000 – Is the $50 Barrier Next?

Silver Soars to Record Highs as Gold Hits $4,000 – Is the $50 Barrier Next?

Silver’s Historic Surge in 2025 Silver’s ascent in 2025 has been nothing short of stunning. The metal started the year in the low $30s but went on a blistering rally, now hovering just below the once-mythical $50/oz mark. On October 8, spot silver spiked to an intraday record ~$49.57 before settling around $49.4 Reuters. By October 9, it traded near…
9 October 2025
···
Webull’s Wild Ride: BULL Stock’s 500% Surge, 85% Crash – Will It Bounce Back?

Webull’s Wild Ride: BULL Stock’s 500% Surge, 85% Crash – Will It Bounce Back?

Company Overview Webull is a digital brokerage platform that offers commission-free trading of stocks, ETFs, options, and cryptocurrencies via a sleek mobile app and web interface ts2.tech. Often likened to Robinhood, Webull monetizes primarily through payment for order flow and premium add-on services (like subscriptions for advanced data) ts2.tech ts2.tech. The platform launched in the U.S. in 2018 and quickly…
9 October 2025
····
Webull’s Wild Ride: Inside BULL Stock’s 500% Surge, 85% Crash & What’s Next for the Trading App Giant

Webull’s Wild Ride: Inside BULL Stock’s 500% Surge, 85% Crash & What’s Next for the Trading App Giant

Company Overview Webull is a digital investment platform that offers commission-free trading of stocks, ETFs, options, cryptocurrencies and more via a popular mobile app and web interface Cmcmarkets. Often likened to Robinhood, Webull makes money primarily through payment for order flow and premium add-on services Cmcmarkets. The platform launched in 2018 and quickly gained traction among tech-savvy retail investors with its sleek…
8 October 2025
···
Tilray Stock Skyrockets 300% on Cannabis Reform Hopes – Is TLRY’s Rally Sustainable?

Tilray Stock Skyrockets 300% on Cannabis Reform Hopes – Is TLRY’s Rally Sustainable?

Tilray’s Stock Price Soars on Reform Speculation Tilray’s stock has been on a tear in recent months, staging a stunning turnaround from penny-stock levels. The share price has quadrupled since early July – rising from well under $0.5 to around $1.7 by early October Nasdaq. Year-to-date, TLRY is up ~22% (as of Oct. 8) after being down over 20% mid-year Talkmarkets Hi Plainscoop. This…
8 October 2025
····
Tilray Stock Skyrockets 300% on Cannabis Reform Hopes – Will TLRY’s Rally Last?

Tilray Stock Skyrockets 300% on Cannabis Reform Hopes – Will TLRY’s Rally Last?

Recent News & Stock Performance (October 2025) Tilray’s stock has been on a wild ride in early October 2025, propelled by a flurry of cannabis policy news. In the first week of October, TLRY jumped over 8% in one day (Oct 7) after an apparent breakthrough in U.S. marijuana reform sentiment Nasdaq Nasdaq. The trigger: several prominent Republican senators voiced…
8 October 2025
····
1 … 230 231 232 233 234 … 240

Stock Market Today

  • SanDisk Stock Soars 1,500% on AI-Driven Demand, Consumer Revenue Also Surges
    January 31, 2026, 9:13 AM EST. SanDisk's stock price surged over 1,500% in nearly a year, reaching an opening peak of $650 before settling at $588. This leap is fueled by a 7.7-fold increase in profits to $803 million, driven largely by strong demand from AI data centers, hyperscalers, and enterprise clients, whose revenue grew 76%. Industrial and automotive segments rose 63%, while consumer revenue climbed 52%. CEO David Goeckeler highlighted the company's strategic product mix and role in AI technology. SanDisk plans to double prices for its 3D NAND enterprise solid-state drives (SSDs) this quarter amid growing AI infrastructure needs, reflecting a broader trend of rising memory chip costs. The expanded joint venture with Kioxia aims to launch next-gen 3D NAND in 2026, signaling ongoing investment in advanced memory solutions.
Go toTop